Funded Startups in Plymouth
Among the 16 most recent Plymouth-linked entries shown, the largest disclosed round is Idrx’s $120M (2024-08-07).
Among the 16 most recent Plymouth-linked entries shown, the largest disclosed round is Idrx’s $120M (2024-08-07). That figure is a clear outlier versus the next-highest disclosed amounts of $88M (Endogenex, 2024-06-25) and $28M (Venture Med Group, 2025-11-03), with most other disclosed rounds landing far below $20M (e.g., Reprise Biomedical $15M on 2023-01-03; Laplace Interventional $22M on 2025-03-16). Disclosed amounts also show a tight geography pattern: 11 of 16 rows list Plymouth, Minnesota, while the remaining entries split across Plymouth, Massachusetts (Idrx; 2024-08-07), Plymouth, New Hampshire (Voices Against Violence; undisclosed, 2023-06-21), Plymouth, United Kingdom (Imployable; $200K, 2022-04-25), and Plymouth, Indiana (SIMBA Chain; $100K, 2022-02-10).
The dataset spans 2021-04-01 (WellWay, Venture - Series Unknown; $2M) through 2025-11-03 (Venture Med Group, Series C; $28M), with notable concentration in late 2024–2025 where multiple Healthcare/Biotechnology rounds appear: Idrx ($120M, 2024-08-07), Endogenex ($88M, 2024-06-25), Laplace Interventional ($22M, 2025-03-16), and Venture Med Group ($28M, 2025-11-03). Sector-wise, Healthcare/Medical Devices and Biotechnology account for much of the list (with Health Care, Biotechnology, and related labels appearing repeatedly), while disclosure is uneven: 4 of 16 rows show “undisclosed” or “Series Unknown” amounts (HistoSonics; Voices Against Violence; Esperovax; World Data Products).
Most recent rounds
16 shownRelated listings
Frequently asked
What’s the largest disclosed round in the Plymouth list, and how does it compare to the rest of the disclosed amounts?
The largest disclosed amount is Idrx’s $120M (2024-08-07, Plymouth, Massachusetts). The next-largest disclosed amounts are Endogenex’s $88M (2024-06-25) and Venture Med Group’s $28M (2025-11-03), with many other disclosed entries below $20M (e.g., Reprise Biomedical $15M on 2023-01-03; Monteris Medical $14M on 2022-09-13).
Is Plymouth, Minnesota over-represented compared with other Plymouth cities?
Yes. 11 of 16 rows list Plymouth, Minnesota (e.g., Endogenex $88M on 2024-06-25; Clearfield $120M on 2022-12-06; WellWay $2M on 2021-04-01). The remaining rows are spread across Plymouth, Massachusetts (Idrx $120M), Plymouth, Indiana (SIMBA Chain $100K), Plymouth, New Hampshire (Voices Against Violence, undisclosed), and Plymouth, United Kingdom (Imployable $200K).
Do the most recent rounds cluster into a narrow time window?
The dataset shows a late-period cluster from 2024-06-25 through 2025-11-03, including Endogenex $88M (2024-06-25), Idrx $120M (2024-08-07), Laplace Interventional $22M (2025-03-16), and Venture Med Group $28M (2025-11-03). Earlier disclosed rounds also appear, but the biggest disclosed amounts are concentrated in this late 2024–2025 span.
What stage mix appears most often, and are “Series Unknown”/undisclosed entries common?
“Series Unknown” and “undisclosed” recur frequently: HistoSonics (undisclosed, 2025-08-07), Esperovax (Series Unknown, $1M, 2023-10-03), Voices Against Violence (Series Unknown, undisclosed, 2023-06-21), World Data Products (Undisclosed, $700K, 2022-03-21), plus multiple “Venture - Series Unknown” entries such as WellWay ($2M, 2021-04-01). In contrast, clearly labeled rounds like Series C (Venture Med Group $28M on 2025-11-03; Laplace Interventional $22M on 2025-03-16; Endogenex $88M on 2024-06-25) are concentrated in the large-disclosed portion of the list.
Are there outliers worth flagging beyond the largest round?
Yes—disclosure and scale diverge. At the low end of disclosed amounts, IMployable’s $200K (2022-04-25) and SIMBA Chain’s $100K (2022-02-10) sit well below the next-tier disclosed amounts, while the largest disclosed rounds (Idrx $120M on 2024-08-07 and Clearfield $120M on 2022-12-06) stand in the same top range, far above most other disclosed entries.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.